€6.49
1.03%
Borsa Italiana, Oct 15, 05:35 pm CEST. Closed.
ISIN
NL0015435975
Symbol
CPR

Davide Campari-Milano Stock price

€6.49
+0.46 7.60% 1M
-0.11 1.73% 6M
+0.95 17.12% YTD
+1.05 19.36% 1Y
-4.58 41.38% 3Y
-6.44 49.84% 5Y
+1.75 36.98% 10Y
-0.93 12.59% 20Y
Borsa Italiana, Closing price Thu, Oct 15 2026
+0.07 1.03%
ISIN
NL0015435975
Symbol
CPR
Industry

AI Insights on Davide Campari-Milano Insights AI Insights on Davide Campari-Milano

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Davide Campari-Milano a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
€7.5b
Enterprise Value
€9.5b
Net debt
€2.0b
Cash
€712.0m
Shares outstanding
1.8b
Valuation
P/E
27.9
P/S | estimate
2.5 | 2.4
EV/Sales | estimate
3.1 | 3.1
EV/FCF | ex SBC
34.6 | 37.1
P/B
1.9
Dividends
DPS
€0.10
Yield 1Y | 5Y
1.6% | 0.8%
Growth 1Y | 5Y
53.8% | 12.7%
Payout 1Y | 3Y
34.5% | 30.7%
Increased
1 Year
Financials
Revenue | estimate
€3.0b | €3.1b
EBITDA
€609.2m
EBIT
€556.8m
Net Income
€268.9m
Free Cash Flow | ex SBC
€273.6m | €254.8m
Growth
Revenue | estimate
-18.8% | 1.2%
EBITDA
-26.5%
EBIT
-28.7%
Net Income
-9.0%
Free Cash Flow
-14.7%
Margin
Gross
59.7%
EBITDA
20.1%
EBIT
18.3%
Net
8.9%
Free Cash Flow | ex SBC
9.0% | 8.4%
Financial Health
Equity Ratio
47.6%
Return on Equity
9.0%
ROCE
7.9%
ROIC
5.5%
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
€18.8m | 0.6%
SBC as % of FCF
6.9%
SBC Growth 1Y
-41.6%
Share Count Growth 1Y
-0.6%
Shareholder Yield
2.2%
More
EPS
€0.2
FCF per Share
€0.2
Short interest
-
Employees
5k
Rev per Employee
€630.0k

Davide Campari-Milano Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Davide Campari-Milano forecast:

13x Buy
48%
13x Hold
48%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Davide Campari-Milano forecast:

Buy
48%
Hold
48%
Sell
4%

Davide Campari-Milano Events

Upcoming Event
OCT
28
Q3 2026 Earnings Call
in 13 days
Past Events
JUL
29
Q2 2026 Earnings Call
3 months ago
MAY
6
Q1 2026 Earnings Call
5 months ago
MAR
4
Q4 2025 Earnings Call
8 months ago
OCT
29
Q3 2025 Earnings Call
12 months ago

Financial data from Davide Campari-Milano

Jun '26
+/-
%
3,035 3,035
19% 19%
100%
- Direct Costs 1,222 1,222
21% 21%
40%
1,813 1,813
17% 17%
60%
- Selling and Administrative Expenses 1,191 1,191
13% 13%
39%
- Research and Development Expense 13 13
-
0%
609 609
26% 26%
20%
- Depreciation and Amortization 52 52
9% 9%
2%
EBIT (Operating Income) EBIT 557 557
29% 29%
18%
Net Profit 269 269
9% 9%
9%

In millions EUR.

Don't miss a Thing! We will send you all news about Davide Campari-Milano directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Davide Campari-Milano NV is a holding company, which engages in the production and distribution of alcoholic and non-alcoholic beverages. The firm operates through its geographic segments: the Americas; Southern Europe; Middle East and Africa; Northern, Central and Eastern Europe; Asia-Pacific. Its product offerings include aperitifs, vodka, whisky, tequila, rum, gin, liqueurs, and sparkling and still wines under internation brands which include Campari, Aperol, Sky Vodka, Wild Turkey, Appleton Estate, Grand Marnier, and Wray and Nephew. The company was founded by Gaspare Campari in 1860 and is headquartered in Sesto San Giovanni, Italy.

Head office Italy
CEO Mr. Marchesini
Employees 4,807
Founded 1996
Website www.camparigroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today